zidovudine has been researched along with hi 236 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mao, C; Sudbeck, EA; Uckun, FM; Venkatachalam, TK | 1 |
| Dong, Y; Narla, RK; Sudbeck, EA; Trieu, VN; Uckun, FM; Venkatachalam, TK | 1 |
2 other study(ies) available for zidovudine and hi 236
| Article | Year |
|---|---|
Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus.
Topics: Anti-HIV Agents; Delavirdine; Drug Design; Humans; Inhibitory Concentration 50; Kinetics; Models, Molecular; Nevirapine; Pyridines; Thiourea | 1999 |
Antioxidant function of phenethyl-5-bromo-pyridyl thiourea compounds with potent anti-HIV activity.
Topics: Anti-HIV Agents; Antioxidants; B-Lymphocytes; Crystallography, X-Ray; Flow Cytometry; Fluorescence; Free Radical Scavengers; HIV Reverse Transcriptase; Humans; Hydrogen Peroxide; Pyridines; Structure-Activity Relationship; T-Lymphocytes; Thiourea | 2000 |